Cover Image

Does growth hormone-releasing factor assist follicular development in poor responder patients undergoing ovarian stimulation for in-vitro fertilization?

Treatment with growth hormone-releasing factor (GRF) has been reported to improve the ovarian response to gonadotrophins in women who respond poorly to ovarian stimulation during in-vitro fertilization (IVF). The efficacy and tolerability of GRF were studied in a randomized, double-blind, placebo-co...

Full description

Saved in:
Bibliographic Details
Main Authors: Howles, Colin M. (Author) , Loumaye, E. (Author) , Germond, M. (Author) , Yates, R. (Author) , Brinsden, P. (Author) , Healy, D. (Author) , Bonaventura, L.M. (Author) , Strowitzki, Thomas (Author)
Format: Article (Journal)
Language:English
Published: 01 August 1999
In: Human reproduction
Year: 1999, Volume: 14, Issue: 8, Pages: 1939-1943
ISSN:1460-2350
DOI:10.1093/humrep/14.8.1939
Online Access:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1093/humrep/14.8.1939
Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/humrep/article/14/8/1939/2913155
Get full text
Author Notes:C.M. Howles, E. Loumaye, M. Germond, R. Yates, P. Brinsden, D. Healy, L.M. Bonaventura and T. Strowitzki
Description
Summary:Treatment with growth hormone-releasing factor (GRF) has been reported to improve the ovarian response to gonadotrophins in women who respond poorly to ovarian stimulation during in-vitro fertilization (IVF). The efficacy and tolerability of GRF were studied in a randomized, double-blind, placebo-controlled trial involving 196 patients.
Item Description:Gesehen am 25.11.2020
Physical Description:Online Resource
ISSN:1460-2350
DOI:10.1093/humrep/14.8.1939

Similar Items